SCHEMBL9938562

SCHEMBL9938562

NC(=S)OCC(=O)O.NC(O)=S

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
CTH P32929 1/20 0.43
CBS P35520 1/20 0.43
THPO P40225 1/20 0.43
THRB P10828 1/20 0.42
CYP1A2 P05177 1/20 0.34
PAM P19021 3/20 0.34
GAA P10253 1/20 0.32
GLRA1 P23415 1/20 0.32
SLC6A9 P48067 1/20 0.32
OR51E2 Q9H255 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALOX15 P16050 2/20 0.31
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10521802 0.97 TSHR (0.42) TSHRCTHCBSTHPOTHRB
SCHEMBL9937835 0.97
SCHEMBL27697820 0.88 TSHR (0.39) TSHRCTHCBSTHPOTHRB
SCHEMBL4399425 0.75 TSHR (0.43) TSHRCTHCBSTHPOTHRB
SCHEMBL3643770 0.75
SCHEMBL27975909 0.74
SCHEMBL4556035 0.74
SCHEMBL7177896 0.71 TSHR (0.31) TSHR
SCHEMBL9540711 0.70
SCHEMBL11058019 0.70 HPGD (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099320-A1 TERPOLYMER COMPOSITIONS, METHODS FOR THEIR PREPARATION, AND THEIR USE FOR SEPARATING MINERALS CYTEC INDUSTRIES INC. (US) 2026-05-15 WO claimed
WO-2026099320-A1 TERPOLYMER COMPOSITIONS, METHODS FOR THEIR PREPARATION, AND THEIR USE FOR SEPARATING MINERALS CYTEC INDUSTRIES INC. (US) 2026-05-15 WO disclosed
CN-110035829-B Depressant composition and method for depressing gangue sulfide minerals during flotation of sulfide ores 塞特工业公司 2021-12-24 CN disclosed
US-10710099-B2 Compositions and methods for selective separation of minerals from sulfide ores CYTEC INDUSTRIES INC. (US) 2020-07-14 US disclosed
US-20190336984-A1 COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF MINERALS FROM SULFIDE ORES CYTEC INDUSTRIES INC. (US) 2019-11-07 US disclosed
US-20190300389-A1 METHOD FOR REMOVING METAL IONS FROM AQUEOUS SOLUTION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-10-03 US disclosed
US-20190300390-A1 DITHIOCARBAMATE ALKALI METAL CROSS-LINKED RESIN FOR ADSORBING METAL IONS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-10-03 US disclosed
US-10427953-B1 Dithiocarbamate alkali metal cross-linked resin for adsorbing metal ions KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-10-01 US disclosed
US-10407318-B1 Method for removing metal ions from aqueous solution KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-09-10 US disclosed
US-10370266-B2 Cross-linked polymeric resin and methods for wastewater treatment KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-08-06 US disclosed
CN-108049063-A Cotton fabric one-bath DSB method short-flow pre-treating process 绍兴恒钧环保科技有限公司 2018-05-18 CN disclosed
US-20180099293-A1 COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF MINERALS FROM SULFIDE ORES CYTEC INDUSTRIES INC. 2018-04-12 US disclosed
EP-3287442-A1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER Richardson, Des R (AU) 2018-02-28 EP disclosed
US-20170341955-A1 CROSS-LINKED POLYMERIC RESIN AND METHODS FOR WASTEWATER TREATMENT KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-11-30 US disclosed
EP-2651894-B1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER RICHARDSON DES R (AU) 2017-08-23 EP disclosed
US-8927580-B2 Thiosemicarbazone compounds and use in the treatment of cancer Oncochel Therapeutics LLC (US) 2015-01-06 US disclosed
US-20140206725-A1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER ONCOCHEL THERAPEUTICS, LLC 2014-07-24 US disclosed
EP-2651894-A1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER Richardson, Des R (AU) 2013-10-23 EP disclosed
WO-2012079128-A1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER RICHARDSON DES R (AU) 2012-06-21 WO disclosed
US-4877518-A SELECTIVE DEPRESSION OF MINERALS IN PULP, RECOVERY OF DESIRED MINERALS IN FROTH PHILLIPS PETROLEUM COMPANY (US) 1989-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206725-A1 THIOSEMICARBAZONE COMPOUNDS AND USE IN THE TREATMENT OF CANCER ETV6, TPMT, ABCB1 TSHR 262/4885CTH 281/4885CBS 605/4885
US-20190336984-A1 COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF MINERALS FROM SULFIDE ORES TST, CTH, PFAS TSHR 939/4885CTH 2/4885CBS 8/4885
US-10710099-B2 Compositions and methods for selective separation of minerals from sulfide ores TST, CTH, PFAS TSHR 939/4885CTH 2/4885CBS 8/4885
US-20180099293-A1 COMPOSITIONS AND METHODS FOR SELECTIVE SEPARATION OF MINERALS FROM SULFIDE ORES TST, CTH, PFAS TSHR 939/4885CTH 2/4885CBS 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.